Use of genome sequencing to identify hepatitis C virus transmission in a renal healthcare setting

Published:January 16, 2017DOI:https://doi.org/10.1016/j.jhin.2017.01.002

      Summary

      Background

      Hepatitis C virus (HCV) infection is a major health burden worldwide. A patient with no history of HCV infection while on a renal unit was found to seroconvert to HCV.

      Aim

      To report the use of sequencing to postulate how transmission of HCV occurred in a healthcare setting, and how this guided our outbreak investigation.

      Findings

      Based on infection control inspections the transmission event was surmised to be due to ward environmental contamination with blood and subsequent inoculation from intravenous interventions on the patient acquiring HCV. We discuss the interventions put in place in response to the outbreak investigation findings.

      Conclusion

      Sequencing of healthcare-acquired HCV infections should be undertaken as routine practice in outbreak investigations.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Webster D.P.
        • Klenerman P.
        • Dusheiko G.M.
        Hepatitis C.
        Lancet. 2015; 385: 1124-1135
        • Bull R.A.
        • Eltahla A.A.
        • Rodrigo C.
        • et al.
        A method for near full-length amplification and sequencing for six hepatitis C virus genotypes.
        BMC Genomics. 2016; 17: 247
        • Mohd Hanafiah K.
        • Groeger J.
        • Flaxman A.D.
        • Wiersma S.T.
        Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.
        Hepatology. 2013; 57: 1333-1342
        • Public Health England
        Hepatitis C in the UK.
        2015 (Available at:) ([last accessed January 2017])
        • Duong C.M.
        • McLaws M.L.
        An investigation of an outbreak of hepatitis C virus infections in a low-resourced hemodialysis unit in Vietnam.
        Am J Infect Control. 2016; 44: 560-566
        • Quer J.
        • Gregori J.
        • Rodríguez-Frias F.
        • et al.
        High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.
        J Clin Microbiol. 2015; 53: 219-226
        • Murphy D.G.
        • Willems B.
        • Deschenes M.
        • Hilzenrat N.
        • Mousseaub R.
        • Sabbah S.
        Use of sequence ananlysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E and 5′ untranslated region sequences.
        J Clin Microbiol. 2007; 45: 1102-1112
        • Laperche S.
        • Lunel F.
        • Izopet J.
        • et al.
        Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing method in a multicenter study.
        J Clin Microbiol. 2005; 42: 733-739
        • May S.
        • Ngui S.L.
        • Collins S.
        • et al.
        Molecular epidemiology of newly acquired hepatitis C infections in England 2008–2011: genotype, phylogeny and mutation analysis.
        J Clin Virol. 2015; 64: 6-11
        • Public Health England
        Communicable disease outbreak management. Operational guidance.
        2014 (Available at:) ([last accessed January 2017])
        • Nasu A.
        • Marusawa H.
        • Ueda Y.
        • et al.
        Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing.
        PLoS One. 2011; 6: e24907
        • Tomkins S.E.
        • Rice B.D.
        • Roy K.
        • Cullen B.
        • Ncube F.M.
        Universal treatment success among healthcare workers diagnosed with occupationally acquired acute hepatitis C.
        J Hosp Infect. 2015; 89: 69-71
      1. Health and Safety Executive. Advisory Committee on dangerous pathogens protection against blood-borne infections in the workplace: HIV and hepatitis. Available at: http://www.hse.gov.uk/biosafety/diseases/bbv.pdf [last accessed January 2017].

        • European Association for the Study of the Liver
        EASL Clinical Practice Guidelines: management of hepatitis C virus infection.
        J Hepatol. 2014; 60: 92-420
        • World Health Organization
        Guidelines on hand hygiene in health Care. First Global Patient Safety Challenge – Clean Care is Safer Care.
        2009 (Available at:) ([last accessed January 2017])
        • Scheel T.K.
        • Rice C.M.
        Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.
        Nat Med. 2013; 19: 837-849
        • Kokubo S.
        • Horii T.
        • Yonekawa O.
        • Ozawa N.
        • Mukaide M.
        A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C in a haemodialysis unit.
        J Viral Hep. 2002; 9: 450-454
        • Abacioglu Y.H.
        • Bacaksiz F.
        • Bahar I.H.
        • Simmonds P.
        Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit.
        Eur J Clin Microbiol Infect Dis. 2000; 19: 182-186
        • Food Standards Agency
        Safe catering – your guide to making food safely.
        2015 ([last accessed January 2017])
        • Ross R.S.
        • Viazov S.
        • Gross T.
        • Hofmann F.
        • Siepp H.M.
        • Roggendorf M.
        Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients.
        N Engl J Med. 2000; 343: 1851-1854